Report Overview
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
The global Emerging Infectious Disease market size was estimated at USD 19350 million in 2023 and is projected to reach USD 32414.89 million by 2032, exhibiting a CAGR of 5.90% during the forecast period.
North America Emerging Infectious Disease market size was estimated at USD 5564.92 million in 2023, at a CAGR of 5.06% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Emerging Infectious Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Emerging Infectious Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Emerging Infectious Disease market in any manner.
Global Emerging Infectious Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BD
Abbott
Roche Diagnostics
Merck & Co.
Inc.
GlaxoSmithKline plc
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Market Segmentation (by Type)
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
Market Segmentation (by Application)
Clinical Laboratories
Diagnostic Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Emerging Infectious Disease Market
Overview of the regional outlook of the Emerging Infectious Disease Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Emerging Infectious Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Emerging Infectious Disease, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Emerging Infectious Disease
1.2 Key Market Segments
1.2.1 Emerging Infectious Disease Segment by Type
1.2.2 Emerging Infectious Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Emerging Infectious Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Emerging Infectious Disease Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Emerging Infectious Disease Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Emerging Infectious Disease Market Competitive Landscape
3.1 Global Emerging Infectious Disease Sales by Manufacturers (2019-2025)
3.2 Global Emerging Infectious Disease Revenue Market Share by Manufacturers (2019-2025)
3.3 Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Emerging Infectious Disease Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Emerging Infectious Disease Sales Sites, Area Served, Product Type
3.6 Emerging Infectious Disease Market Competitive Situation and Trends
3.6.1 Emerging Infectious Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Emerging Infectious Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Emerging Infectious Disease Industry Chain Analysis
4.1 Emerging Infectious Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Emerging Infectious Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Emerging Infectious Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Emerging Infectious Disease Sales Market Share by Type (2019-2025)
6.3 Global Emerging Infectious Disease Market Size Market Share by Type (2019-2025)
6.4 Global Emerging Infectious Disease Price by Type (2019-2025)
7 Emerging Infectious Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Emerging Infectious Disease Market Sales by Application (2019-2025)
7.3 Global Emerging Infectious Disease Market Size (M USD) by Application (2019-2025)
7.4 Global Emerging Infectious Disease Sales Growth Rate by Application (2019-2025)
8 Emerging Infectious Disease Market Consumption by Region
8.1 Global Emerging Infectious Disease Sales by Region
8.1.1 Global Emerging Infectious Disease Sales by Region
8.1.2 Global Emerging Infectious Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Emerging Infectious Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Emerging Infectious Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Emerging Infectious Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Emerging Infectious Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Emerging Infectious Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Emerging Infectious Disease Market Production by Region
9.1 Global Production of Emerging Infectious Disease by Region (2019-2025)
9.2 Global Emerging Infectious Disease Revenue Market Share by Region (2019-2025)
9.3 Global Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Emerging Infectious Disease Production
9.4.1 North America Emerging Infectious Disease Production Growth Rate (2019-2025)
9.4.2 North America Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Emerging Infectious Disease Production
9.5.1 Europe Emerging Infectious Disease Production Growth Rate (2019-2025)
9.5.2 Europe Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Emerging Infectious Disease Production (2019-2025)
9.6.1 Japan Emerging Infectious Disease Production Growth Rate (2019-2025)
9.6.2 Japan Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Emerging Infectious Disease Production (2019-2025)
9.7.1 China Emerging Infectious Disease Production Growth Rate (2019-2025)
9.7.2 China Emerging Infectious Disease Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 BD
10.1.1 BD Emerging Infectious Disease Basic Information
10.1.2 BD Emerging Infectious Disease Product Overview
10.1.3 BD Emerging Infectious Disease Product Market Performance
10.1.4 BD Business Overview
10.1.5 BD Emerging Infectious Disease SWOT Analysis
10.1.6 BD Recent Developments
10.2 Abbott
10.2.1 Abbott Emerging Infectious Disease Basic Information
10.2.2 Abbott Emerging Infectious Disease Product Overview
10.2.3 Abbott Emerging Infectious Disease Product Market Performance
10.2.4 Abbott Business Overview
10.2.5 Abbott Emerging Infectious Disease SWOT Analysis
10.2.6 Abbott Recent Developments
10.3 Roche Diagnostics
10.3.1 Roche Diagnostics Emerging Infectious Disease Basic Information
10.3.2 Roche Diagnostics Emerging Infectious Disease Product Overview
10.3.3 Roche Diagnostics Emerging Infectious Disease Product Market Performance
10.3.4 Roche Diagnostics Emerging Infectious Disease SWOT Analysis
10.3.5 Roche Diagnostics Business Overview
10.3.6 Roche Diagnostics Recent Developments
10.4 Merck and Co.
10.4.1 Merck and Co. Emerging Infectious Disease Basic Information
10.4.2 Merck and Co. Emerging Infectious Disease Product Overview
10.4.3 Merck and Co. Emerging Infectious Disease Product Market Performance
10.4.4 Merck and Co. Business Overview
10.4.5 Merck and Co. Recent Developments
10.5 Inc.
10.5.1 Inc. Emerging Infectious Disease Basic Information
10.5.2 Inc. Emerging Infectious Disease Product Overview
10.5.3 Inc. Emerging Infectious Disease Product Market Performance
10.5.4 Inc. Business Overview
10.5.5 Inc. Recent Developments
10.6 GlaxoSmithKline plc
10.6.1 GlaxoSmithKline plc Emerging Infectious Disease Basic Information
10.6.2 GlaxoSmithKline plc Emerging Infectious Disease Product Overview
10.6.3 GlaxoSmithKline plc Emerging Infectious Disease Product Market Performance
10.6.4 GlaxoSmithKline plc Business Overview
10.6.5 GlaxoSmithKline plc Recent Developments
10.7 BioMerieux
10.7.1 BioMerieux Emerging Infectious Disease Basic Information
10.7.2 BioMerieux Emerging Infectious Disease Product Overview
10.7.3 BioMerieux Emerging Infectious Disease Product Market Performance
10.7.4 BioMerieux Business Overview
10.7.5 BioMerieux Recent Developments
10.8 Danaher
10.8.1 Danaher Emerging Infectious Disease Basic Information
10.8.2 Danaher Emerging Infectious Disease Product Overview
10.8.3 Danaher Emerging Infectious Disease Product Market Performance
10.8.4 Danaher Business Overview
10.8.5 Danaher Recent Developments
10.9 Orasure
10.9.1 Orasure Emerging Infectious Disease Basic Information
10.9.2 Orasure Emerging Infectious Disease Product Overview
10.9.3 Orasure Emerging Infectious Disease Product Market Performance
10.9.4 Orasure Business Overview
10.9.5 Orasure Recent Developments
10.10 Qiagen
10.10.1 Qiagen Emerging Infectious Disease Basic Information
10.10.2 Qiagen Emerging Infectious Disease Product Overview
10.10.3 Qiagen Emerging Infectious Disease Product Market Performance
10.10.4 Qiagen Business Overview
10.10.5 Qiagen Recent Developments
10.11 Quidel
10.11.1 Quidel Emerging Infectious Disease Basic Information
10.11.2 Quidel Emerging Infectious Disease Product Overview
10.11.3 Quidel Emerging Infectious Disease Product Market Performance
10.11.4 Quidel Business Overview
10.11.5 Quidel Recent Developments
10.12 Sysmex
10.12.1 Sysmex Emerging Infectious Disease Basic Information
10.12.2 Sysmex Emerging Infectious Disease Product Overview
10.12.3 Sysmex Emerging Infectious Disease Product Market Performance
10.12.4 Sysmex Business Overview
10.12.5 Sysmex Recent Developments
10.13 Gen-Probe
10.13.1 Gen-Probe Emerging Infectious Disease Basic Information
10.13.2 Gen-Probe Emerging Infectious Disease Product Overview
10.13.3 Gen-Probe Emerging Infectious Disease Product Market Performance
10.13.4 Gen-Probe Business Overview
10.13.5 Gen-Probe Recent Developments
10.14 Cepheid
10.14.1 Cepheid Emerging Infectious Disease Basic Information
10.14.2 Cepheid Emerging Infectious Disease Product Overview
10.14.3 Cepheid Emerging Infectious Disease Product Market Performance
10.14.4 Cepheid Business Overview
10.14.5 Cepheid Recent Developments
10.15 Hologic
10.15.1 Hologic Emerging Infectious Disease Basic Information
10.15.2 Hologic Emerging Infectious Disease Product Overview
10.15.3 Hologic Emerging Infectious Disease Product Market Performance
10.15.4 Hologic Business Overview
10.15.5 Hologic Recent Developments
11 Emerging Infectious Disease Market Forecast by Region
11.1 Global Emerging Infectious Disease Market Size Forecast
11.2 Global Emerging Infectious Disease Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Emerging Infectious Disease Market Size Forecast by Country
11.2.3 Asia Pacific Emerging Infectious Disease Market Size Forecast by Region
11.2.4 South America Emerging Infectious Disease Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Emerging Infectious Disease by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Emerging Infectious Disease Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Emerging Infectious Disease by Type (2025-2032)
12.1.2 Global Emerging Infectious Disease Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Emerging Infectious Disease by Type (2025-2032)
12.2 Global Emerging Infectious Disease Market Forecast by Application (2025-2032)
12.2.1 Global Emerging Infectious Disease Sales (K Units) Forecast by Application
12.2.2 Global Emerging Infectious Disease Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Emerging Infectious Disease Market Size Comparison by Region (M USD)
Table 5. Global Emerging Infectious Disease Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Emerging Infectious Disease Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Emerging Infectious Disease Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Emerging Infectious Disease Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Infectious Disease as of 2022)
Table 10. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Emerging Infectious Disease Sales Sites and Area Served
Table 12. Manufacturers Emerging Infectious Disease Product Type
Table 13. Global Emerging Infectious Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Emerging Infectious Disease
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Emerging Infectious Disease Market Challenges
Table 22. Global Emerging Infectious Disease Sales by Type (K Units)
Table 23. Global Emerging Infectious Disease Market Size by Type (M USD)
Table 24. Global Emerging Infectious Disease Sales (K Units) by Type (2019-2025)
Table 25. Global Emerging Infectious Disease Sales Market Share by Type (2019-2025)
Table 26. Global Emerging Infectious Disease Market Size (M USD) by Type (2019-2025)
Table 27. Global Emerging Infectious Disease Market Size Share by Type (2019-2025)
Table 28. Global Emerging Infectious Disease Price (USD/Unit) by Type (2019-2025)
Table 29. Global Emerging Infectious Disease Sales (K Units) by Application
Table 30. Global Emerging Infectious Disease Market Size by Application
Table 31. Global Emerging Infectious Disease Sales by Application (2019-2025) & (K Units)
Table 32. Global Emerging Infectious Disease Sales Market Share by Application (2019-2025)
Table 33. Global Emerging Infectious Disease Sales by Application (2019-2025) & (M USD)
Table 34. Global Emerging Infectious Disease Market Share by Application (2019-2025)
Table 35. Global Emerging Infectious Disease Sales Growth Rate by Application (2019-2025)
Table 36. Global Emerging Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 37. Global Emerging Infectious Disease Sales Market Share by Region (2019-2025)
Table 38. North America Emerging Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 39. Europe Emerging Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Emerging Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 41. South America Emerging Infectious Disease Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Emerging Infectious Disease Sales by Region (2019-2025) & (K Units)
Table 43. Global Emerging Infectious Disease Production (K Units) by Region (2019-2025)
Table 44. Global Emerging Infectious Disease Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Emerging Infectious Disease Revenue Market Share by Region (2019-2025)
Table 46. Global Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Emerging Infectious Disease Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. BD Emerging Infectious Disease Basic Information
Table 52. BD Emerging Infectious Disease Product Overview
Table 53. BD Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. BD Business Overview
Table 55. BD Emerging Infectious Disease SWOT Analysis
Table 56. BD Recent Developments
Table 57. Abbott Emerging Infectious Disease Basic Information
Table 58. Abbott Emerging Infectious Disease Product Overview
Table 59. Abbott Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Abbott Business Overview
Table 61. Abbott Emerging Infectious Disease SWOT Analysis
Table 62. Abbott Recent Developments
Table 63. Roche Diagnostics Emerging Infectious Disease Basic Information
Table 64. Roche Diagnostics Emerging Infectious Disease Product Overview
Table 65. Roche Diagnostics Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Roche Diagnostics Emerging Infectious Disease SWOT Analysis
Table 67. Roche Diagnostics Business Overview
Table 68. Roche Diagnostics Recent Developments
Table 69. Merck and Co. Emerging Infectious Disease Basic Information
Table 70. Merck and Co. Emerging Infectious Disease Product Overview
Table 71. Merck and Co. Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Merck and Co. Business Overview
Table 73. Merck and Co. Recent Developments
Table 74. Inc. Emerging Infectious Disease Basic Information
Table 75. Inc. Emerging Infectious Disease Product Overview
Table 76. Inc. Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Inc. Business Overview
Table 78. Inc. Recent Developments
Table 79. GlaxoSmithKline plc Emerging Infectious Disease Basic Information
Table 80. GlaxoSmithKline plc Emerging Infectious Disease Product Overview
Table 81. GlaxoSmithKline plc Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Recent Developments
Table 84. BioMerieux Emerging Infectious Disease Basic Information
Table 85. BioMerieux Emerging Infectious Disease Product Overview
Table 86. BioMerieux Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. BioMerieux Business Overview
Table 88. BioMerieux Recent Developments
Table 89. Danaher Emerging Infectious Disease Basic Information
Table 90. Danaher Emerging Infectious Disease Product Overview
Table 91. Danaher Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Danaher Business Overview
Table 93. Danaher Recent Developments
Table 94. Orasure Emerging Infectious Disease Basic Information
Table 95. Orasure Emerging Infectious Disease Product Overview
Table 96. Orasure Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Orasure Business Overview
Table 98. Orasure Recent Developments
Table 99. Qiagen Emerging Infectious Disease Basic Information
Table 100. Qiagen Emerging Infectious Disease Product Overview
Table 101. Qiagen Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Qiagen Business Overview
Table 103. Qiagen Recent Developments
Table 104. Quidel Emerging Infectious Disease Basic Information
Table 105. Quidel Emerging Infectious Disease Product Overview
Table 106. Quidel Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Quidel Business Overview
Table 108. Quidel Recent Developments
Table 109. Sysmex Emerging Infectious Disease Basic Information
Table 110. Sysmex Emerging Infectious Disease Product Overview
Table 111. Sysmex Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Sysmex Business Overview
Table 113. Sysmex Recent Developments
Table 114. Gen-Probe Emerging Infectious Disease Basic Information
Table 115. Gen-Probe Emerging Infectious Disease Product Overview
Table 116. Gen-Probe Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Gen-Probe Business Overview
Table 118. Gen-Probe Recent Developments
Table 119. Cepheid Emerging Infectious Disease Basic Information
Table 120. Cepheid Emerging Infectious Disease Product Overview
Table 121. Cepheid Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Cepheid Business Overview
Table 123. Cepheid Recent Developments
Table 124. Hologic Emerging Infectious Disease Basic Information
Table 125. Hologic Emerging Infectious Disease Product Overview
Table 126. Hologic Emerging Infectious Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Hologic Business Overview
Table 128. Hologic Recent Developments
Table 129. Global Emerging Infectious Disease Sales Forecast by Region (2025-2032) & (K Units)
Table 130. Global Emerging Infectious Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Emerging Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 132. North America Emerging Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Emerging Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 134. Europe Emerging Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Emerging Infectious Disease Sales Forecast by Region (2025-2032) & (K Units)
Table 136. Asia Pacific Emerging Infectious Disease Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Emerging Infectious Disease Sales Forecast by Country (2025-2032) & (K Units)
Table 138. South America Emerging Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Emerging Infectious Disease Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Emerging Infectious Disease Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Emerging Infectious Disease Sales Forecast by Type (2025-2032) & (K Units)
Table 142. Global Emerging Infectious Disease Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Emerging Infectious Disease Price Forecast by Type (2025-2032) & (USD/Unit)
Table 144. Global Emerging Infectious Disease Sales (K Units) Forecast by Application (2025-2032)
Table 145. Global Emerging Infectious Disease Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Emerging Infectious Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Emerging Infectious Disease Market Size (M USD), 2019-2032
Figure 5. Global Emerging Infectious Disease Market Size (M USD) (2019-2032)
Figure 6. Global Emerging Infectious Disease Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Emerging Infectious Disease Market Size by Country (M USD)
Figure 11. Emerging Infectious Disease Sales Share by Manufacturers in 2023
Figure 12. Global Emerging Infectious Disease Revenue Share by Manufacturers in 2023
Figure 13. Emerging Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Emerging Infectious Disease Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Emerging Infectious Disease Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Emerging Infectious Disease Market Share by Type
Figure 18. Sales Market Share of Emerging Infectious Disease by Type (2019-2025)
Figure 19. Sales Market Share of Emerging Infectious Disease by Type in 2023
Figure 20. Market Size Share of Emerging Infectious Disease by Type (2019-2025)
Figure 21. Market Size Market Share of Emerging Infectious Disease by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Emerging Infectious Disease Market Share by Application
Figure 24. Global Emerging Infectious Disease Sales Market Share by Application (2019-2025)
Figure 25. Global Emerging Infectious Disease Sales Market Share by Application in 2023
Figure 26. Global Emerging Infectious Disease Market Share by Application (2019-2025)
Figure 27. Global Emerging Infectious Disease Market Share by Application in 2023
Figure 28. Global Emerging Infectious Disease Sales Growth Rate by Application (2019-2025)
Figure 29. Global Emerging Infectious Disease Sales Market Share by Region (2019-2025)
Figure 30. North America Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Emerging Infectious Disease Sales Market Share by Country in 2023
Figure 32. U.S. Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Emerging Infectious Disease Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Emerging Infectious Disease Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Emerging Infectious Disease Sales Market Share by Country in 2023
Figure 37. Germany Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Emerging Infectious Disease Sales Market Share by Region in 2023
Figure 44. China Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 50. South America Emerging Infectious Disease Sales Market Share by Country in 2023
Figure 51. Brazil Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Emerging Infectious Disease Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Emerging Infectious Disease Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Emerging Infectious Disease Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Emerging Infectious Disease Production Market Share by Region (2019-2025)
Figure 62. North America Emerging Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Emerging Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Emerging Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 65. China Emerging Infectious Disease Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Emerging Infectious Disease Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Emerging Infectious Disease Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Emerging Infectious Disease Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Emerging Infectious Disease Market Share Forecast by Type (2025-2032)
Figure 70. Global Emerging Infectious Disease Sales Forecast by Application (2025-2032)
Figure 71. Global Emerging Infectious Disease Market Share Forecast by Application (2025-2032)
